[HTML][HTML] The treatment of advanced melanoma: therapeutic update

A Villani, L Potestio, G Fabbrocini, G Troncone… - International journal of …, 2022 - mdpi.com
Cutaneous melanoma is the main cause of death for skin cancer. The majority of patients
with a diagnosis of melanoma have localized disease, which can be successfully treated …

New therapeutic options for advanced non-resectable malignant melanoma

S Stadler, K Weina, C Gebhardt, J Utikal - Advances in medical sciences, 2015 - Elsevier
Melanoma is a malignant tumor which is inclined to metastasize promptly into the lymphatic
system and other organs such as lung, liver, brain or bone. Therefore early diagnosis …

[HTML][HTML] Melanoma management: from epidemiology to treatment and latest advances

J Lopes, CMP Rodrigues, MM Gaspar, CP Reis - Cancers, 2022 - mdpi.com
Simple Summary Melanoma is a major public health issue that claims the lives of thousands
of people every year. Furthermore, the outlook for the coming years is not encouraging with …

[HTML][HTML] Therapeutic advancements across clinical stages in melanoma, with a focus on targeted immunotherapy

C Trojaniello, JJ Luke, PA Ascierto - Frontiers in Oncology, 2021 - frontiersin.org
Melanoma is the most fatal skin cancer. In the early stages, it can be safely treated with
surgery alone. However, since 2011, there has been an important revolution in the treatment …

Novel approaches to treatment of advanced melanoma: a review on targeted therapy and immunotherapy

A Niezgoda, P Niezgoda… - BioMed research …, 2015 - Wiley Online Library
The incidence of malignant melanoma is increasing. The majority of patients are diagnosed
in early stages when the disease is highly curable. However, the more advanced or …

[HTML][HTML] The current state of treatment and future directions in cutaneous malignant melanoma

M Ernst, A Giubellino - Biomedicines, 2022 - mdpi.com
Malignant melanoma is the leading cause of death among cutaneous malignancies. While
its incidence is increasing, the most recent cancer statistics show a small but clear decrease …

[HTML][HTML] Personalized medicine in malignant melanoma: towards patient tailored treatment

H Helgadottir, I Rocha Trocoli Drakensjö… - Frontiers in …, 2018 - frontiersin.org
Despite enormous international efforts, skin melanoma is still a major clinical challenge.
Melanoma takes a top place among the most common cancer types and it has one of the …

Current and future roles of targeted therapy and immunotherapy in advanced melanoma

AJ Olszanski - Journal of Managed Care Pharmacy, 2014 - jmcp.org
BACKGROUND: Melanoma is an aggressive disease that accounts for approximately 75%
of skin cancer-related deaths. Historically, treatment options for patients with advanced …

Current status and future direction in the management of malignant melanoma

P Gladfelter, NHE Darwish, SA Mousa - Melanoma research, 2017 - journals.lww.com
The incidence of malignant melanoma is increasing rapidly on a global scale. Although
some types of melanoma, for example primary cutaneous melanoma, can be managed by …

[HTML][HTML] Pathways and therapeutic targets in melanoma

E Shtivelman, MA Davies, P Hwu, J Yang, M Lotem… - Oncotarget, 2014 - ncbi.nlm.nih.gov
This review aims to summarize the current knowledge of molecular pathways and their
clinical relevance in melanoma. Metastatic melanoma was a grim diagnosis, but in recent …